drugset / Trial / NCT05063968
A Clinical Trial of XZP-6019 Tablets in Healthy Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will consist of 3 parts: Part A - Single Ascending Dose (SAD) phase, Part B - Food Effect (FE) phase, and Part C - multiple ascending dose (MAD) phase.
Timeline
- Start
- 2021-11-30
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XZP-6019 | Unknown | — | Oral |